Real-world data on the comparison of LDL-C lowering effects between alirocumab and evolocumab. (August 2022)

• Record Type: Journal Article
• Authors: Lin, D.-Y.; Tsai, C.-L.; Chuang, J.-Y.; Liang, C.-H.; Chen, Y.-H.; Chang, Y.-H.; Yeh, H.-I.; Lin, C.-F.
• Is Part Of: Atherosclerosis. Volume 355(2022)
• Page Start: 218
• Publication Date: 2022-08
• Subjects: Arteriosclerosis -- Periodicals; Electronic journals; 616.136
• DOI: 10.1016/j.atherosclerosis.2022.06.858
• Languages: English
• ISSNs: 0021-9150